Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Mace Rothenberg currently holds 25,000 shares of Tango Therapeutics, Inc. (TNGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mace Rothenberg has been a net neutral trader of TNGX stock. They have purchased $0 and sold $0 worth of shares.
Mace Rothenberg's most recent insider trade was on Jun 5, 2026, when they sold 25,000 shares at $0.00 per share.
Mace Rothenberg serves as Executive at Tango Therapeutics, Inc. (TNGX). They have executed 6 insider transactions totaling $0 over their tenure at the company.
Mace Rothenberg holds the position of Executive at Tango Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 3 years and currently hold a stake valued at $0.
Mace Rothenberg has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by Mace Rothenberg was on Jun 5, 2026, when they purchased $0 worth of TNGX shares. This transaction involved 25,000 shares at N/A per share.
Mace Rothenberg currently owns 25,000 shares of Tango Therapeutics, Inc. (TNGX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Mace Rothenberg's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Mace Rothenberg has 6 Form 4 filings on record as an insider at Tango Therapeutics, Inc..
Set alerts for Mace Rothenberg and 40,000+ other insiders.